| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Actinium Pharmaceuticals, Inc. (ATNM) has 1 insider with recent SEC Form 4 filings, including 6 buys and 91 sells. ATNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 184.5K | $241.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 148,100 | $1.81 | $268,435.98 | -0.1% | |
| Jun 15, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 33,619 | $1.90 | $63,876.10 | -0.6% | |
| Jun 2, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 17,790 | $2.01 | $35,715.80 | -0.2% | |
| Jun 1, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 169,450 | $1.97 | $333,384.51 | -0.2% | |
| May 26, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 40,068 | $1.92 | $77,060.56 | -0.2% | |
| May 25, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 36,400 | $1.90 | $69,235.50 | -0.1% | |
| Apr 26, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 52,577 | $2.04 | $107,265.22 | - | |
| Apr 21, 2016 | Memorial Sloan-Kettering Cancer Center | 10% Owner | Sell | 196,497 | $2.03 | $398,919.43 | -0.2% | |
| Apr 18, 2016 | Seth Sandesh | Director, Executive Chairman | Buy | 10,000 | $1.99 | $19,900.00 | +13.5% | |
| Apr 15, 2016 | Traversa Sergio55 | Director | Buy | 3,000 | $2.02 | $6,060.00 | +150.0% |